Cargando…

Potential biomarkers to follow the progression and treatment response of Huntington’s disease

Huntington’s disease (HD) is a rare genetic disease caused by expanded polyglutamine repeats in the huntingtin protein resulting in selective neuronal loss. Although genetic testing readily identifies those who will be affected, current pharmacological treatments do not prevent or slow down disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Disatnik, Marie-Hélène, Joshi, Amit U., Saw, Nay L., Shamloo, Mehrdad, Leavitt, Blair R., Qi, Xin, Mochly-Rosen, Daria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110026/ https://www.ncbi.nlm.nih.gov/pubmed/27821553 http://dx.doi.org/10.1084/jem.20160776

Ejemplares similares

The challenge in translating basic research discoveries to treatment of Huntington disease
por: Mochly-Rosen, Daria, et al.
Publicado: (2014)

Drp1/Fis1 interaction mediates mitochondrial dysfunction, bioenergetic failure and cognitive decline in Alzheimer's disease
por: Joshi, Amit U., et al.
Publicado: (2017)

Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis
por: Joshi, Amit U, et al.
Publicado: (2018)

Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease
por: Hwang, Sunhee, et al.
Publicado: (2015)

Aberrant mitochondrial fission in neurons induced by protein kinase Cδ under oxidative stress conditions in vivo
por: Qi, Xin, et al.
Publicado: (2011)

New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
por: Disatnik, Marie-Hélène, et al.
Publicado: (2015)

Aldehyde dehydrogenase 2 activation and coevolution of its εPKC-mediated phosphorylation sites
por: Nene, Aishwarya, et al.
Publicado: (2017)

Mitochondrial import of PKCε is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury
por: Budas, Grant R., et al.
Publicado: (2010)

Acute Inhibition of Excessive Mitochondrial Fission After Myocardial Infarction Prevents Long‐term Cardiac Dysfunction
por: Disatnik, Marie‐Hélène, et al.
Publicado: (2013)

VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease
por: Guo, Xing, et al.
Publicado: (2016)

Interaction of mitochondrial fission factor with dynamin related protein 1 governs physiological mitochondrial function in vivo
por: Kornfeld, Opher S., et al.
Publicado: (2018)

Npas4: A Neuronal Transcription Factor with a Key Role in Social and Cognitive Functions Relevant to Developmental Disorders
por: Coutellier, Laurence, et al.
Publicado: (2012)

Activity-dependent modulation of hippocampal synaptic plasticity via PirB and endocannabinoids
por: Djurisic, Maja, et al.
Publicado: (2018)

Longitudinal expression changes are weak correlates of disease progression in Huntington’s disease
por: Mitchell, Christopher T, et al.
Publicado: (2020)

Preface to the Special Issue on “Sleep and Circadian Disorder in Huntington’s Disease”
por: Leavitt, Blair R., et al.
Publicado: (2023)

Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease
por: Mazarei, Gelareh, et al.
Publicado: (2015)

A Computational Cognitive Biomarker for Early-Stage Huntington’s Disease
por: Wiecki, Thomas V., et al.
Publicado: (2016)

Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy
por: Haileselassie, Bereketeab, et al.
Publicado: (2020)

Cerebrospinal fluid biomarkers for assessing Huntington disease onset and severity
por: Caron, Nicholas S, et al.
Publicado: (2022)

A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats
por: Ferreira, Julio C. B., et al.
Publicado: (2019)

Thy1-hAPP(Lond/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function
por: Faizi, Mehrdad, et al.
Publicado: (2012)

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
por: Estevez‐Fraga, Carlos, et al.
Publicado: (2023)

Focus On: The Cardiovascular System: What Did We Learn from the French (Paradox)?
por: Mochly-Rosen, Daria, et al.
Publicado: (2010)

Discovery and Preclinical Work
por: Mochly-Rosen, Daria, et al.
Publicado: (2013)

Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration
por: Joshi, Amit U., et al.
Publicado: (2019)

Alcohol Consumption, ALDH2 Polymorphism as Risk Factors for Upper Aerodigestive Tract Cancer Progression and Prognosis
por: Chen, Che-Hong, et al.
Publicado: (2022)

Structural analysis of clinically relevant pathogenic G6PD variants reveals the importance of tetramerization for G6PD activity
por: Cunningham, Anna D, et al.
Publicado: (2017)

Is TGF-β1 a Biomarker of Huntington’s Disease Progression?
por: Plinta, Klaudia, et al.
Publicado: (2021)

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
por: Byrne, Lauren M, et al.
Publicado: (2017)

Juvenile Huntington’s disease masquerading as progressive myoclonus epilepsy
por: Thakor, Bina, et al.
Publicado: (2021)

Enantiomers of 2-methylglutamate and 2-methylglutamine selectively impact mouse brain metabolism and behavior
por: Wawro, Adam M., et al.
Publicado: (2021)

Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease
por: Bečanović, Kristina, et al.
Publicado: (2021)

Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
por: Joshi, Amit U., et al.
Publicado: (2019)

Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010)

Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease
por: Seike, Takuya, et al.
Publicado: (2023)

Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study
por: Baake, Verena, et al.
Publicado: (2018)

Author Correction: Age-related mitochondrial alterations in brain and skeletal muscle of the YAC128 model of Huntington disease
por: Bečanović, Kristina, et al.
Publicado: (2021)

Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease
por: Rodrigues, Filipe Brogueira, et al.
Publicado: (2016)

Altered Intracortical T(1)-Weighted/T(2)-Weighted Ratio Signal in Huntington’s Disease
por: Rowley, Christopher D., et al.
Publicado: (2018)

Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling
por: Minkova, Lora, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n8cf85v0oppqhhpvh0ctdg66i7